Dog Kidney Disease: Symptoms, IRIS Stages, and Treatment Guide
This article is reviewed for clinical accuracy. Always consult your veterinarian for diagnosis and treatment.
Key Takeaways
- Chronic kidney disease (CKD) in dogs is staged using the International Renal Interest Society (IRIS) classification system, with Stage 1 having no clinical signs and near-normal creatinine, through Stage 4 where creatinine is severely elevated and uremic crisis is common; IRIS staging guides treatment intensity and prognosis discussions.
- The kidneys have approximately 75 percent functional reserve, meaning dogs lose roughly three-quarters of their nephron mass before blood creatinine and BUN rise above the normal reference range; by the time azotemia (elevated blood urea nitrogen and creatinine) is detected on routine bloodwork, significant permanent kidney damage has already occurred.
- SDMA (symmetric dimethylarginine) is a newer biomarker that detects CKD earlier than creatinine, rising when approximately 40 percent of kidney function is lost rather than 75 percent; IDEXX SDMA is now included on most routine chemistry panels and is especially valuable for early detection in senior dogs.
- Dietary phosphorus restriction is the single most important nutritional intervention in CKD; excess phosphorus drives renal secondary hyperparathyroidism, accelerates nephron loss, and is the primary driver of the vicious cycle that causes progression from early to late-stage CKD; prescription renal diets and phosphate binders are the two tools for managing phosphorus.
- Hypertension (systemic high blood pressure) affects approximately 60 to 70 percent of dogs with CKD and causes additional kidney damage, retinal detachment leading to sudden blindness, and cardiac changes; blood pressure measurement is an essential part of every CKD monitoring visit.
- Early-stage CKD managed appropriately with renal diet, blood pressure control, and phosphorus restriction can have a stable course for months to years; end-stage CKD (Stage 4) carries a median survival time measured in weeks to a few months, though individual dogs vary considerably.
The 11-year-old Cocker Spaniel’s owner brought him in for a routine senior wellness exam. He had been slightly quieter than usual for a few months, drank a bit more water, and had lost about two pounds over six months. The owner attributed all of it to aging. The blood panel showed creatinine at 3.1 mg/dL and BUN at 68 mg/dL. Urine specific gravity was 1.015, indicating impaired urine concentrating ability. SDMA was 32 micrograms per deciliter. This dog was IRIS Stage 3 CKD. The owner was stunned: the dog seemed fine. This disconnect between the dog’s apparently normal quality of life and the severity of kidney damage revealed on bloodwork is one of the most important features of canine chronic kidney disease. The kidneys are extraordinarily resilient organs with massive functional reserve, and dogs hide the signs of renal insufficiency until the disease is already well advanced. Understanding what is actually happening inside the kidney during CKD, what the IRIS staging numbers mean in practical terms, and what management can and cannot do is essential for any owner of an older dog.
How the Kidneys Work and Why CKD Progresses
Each kidney contains approximately 400,000 to 800,000 nephrons: the functional filtering units composed of a glomerulus (a capillary tuft that filters blood) and a tubule (which reabsorbs water, electrolytes, glucose, and amino acids, and secretes waste products). The kidneys perform multiple critical functions: excretion of nitrogenous waste products (urea, creatinine, uric acid), regulation of fluid and electrolyte balance, regulation of blood pressure (through the renin-angiotensin-aldosterone system), production of erythropoietin (which stimulates red blood cell production in bone marrow), and activation of vitamin D (which regulates calcium and phosphorus metabolism). When nephrons are damaged and lost, the remaining nephrons hypertrophy and increase their individual filtration rate to compensate. This compensatory hyperfiltration is initially effective but places mechanical strain on the surviving glomeruli, causing progressive glomerulosclerosis (scarring) and tubular atrophy. The surviving nephrons eventually fail as well, creating the self-perpetuating cycle of CKD progression. Phosphorus retention is a key driver of this cycle: damaged kidneys cannot excrete phosphorus normally; elevated serum phosphorus stimulates parathyroid hormone (PTH) secretion (renal secondary hyperparathyroidism); elevated PTH causes calcification of soft tissues including renal tubular cells, direct nephrotoxicity, and further nephron loss. This is why phosphorus restriction is prioritized so strongly in CKD management.
Causes of CKD in Dogs
| Cause | Detail |
|---|---|
| Idiopathic tubulointerstitial nephritis | The most common cause; chronic inflammation and fibrosis of the renal interstitium of unknown origin; affects older dogs of all breeds |
| Glomerulonephritis (immune-mediated) | Immune complex deposition in glomeruli causes proteinuria and progressive glomerulosclerosis; often associated with chronic infections, neoplasia, or Borrelia (Lyme nephritis); breeds at higher risk include Bernese Mountain Dogs, Labrador and Golden Retrievers, Shetland Sheepdogs |
| Hereditary nephropathy / breed-specific | Bull Terriers and Miniature Bull Terriers (hereditary nephritis, X-linked collagen IV defect similar to human Alport syndrome); Cocker Spaniels (familial nephropathy); Cairn Terriers (polycystic kidney disease); Doberman Pinschers (membranoproliferative glomerulopathy); Soft Coated Wheaten Terriers (protein-losing nephropathy and protein-losing enteropathy) |
| Pyelonephritis (chronic bacterial) | Ascending urinary tract infection reaching the renal pelvis; causes focal scarring; often subclinical; associated with glucosuria (diabetes), urinary tract abnormalities |
| Nephrotoxins | NSAIDs (ibuprofen, naproxen, aspirin at high doses, meloxicam in dehydrated dogs), aminoglycoside antibiotics (gentamicin), grapes and raisins (idiosyncratic mechanism, can cause acute kidney injury that progresses to CKD), lily toxicity (Lilium species; irrelevant in dogs, primarily affects cats), heavy metals, ethylene glycol (antifreeze) |
| Leptospirosis | Leptospira interrogans serovars cause acute interstitial nephritis that can progress to CKD; vaccinate dogs with 4-serovar leptospirosis vaccine in endemic areas (where wildlife contact is possible) |
| Hypertensive nephropathy | Systemic hypertension from any cause (hyperadrenocorticism, pheochromocytoma, primary hypertension) causes glomerular hypertension and progressive nephron damage |
| Obstructive nephropathy | Ureteral or urethral obstruction from uroliths, neoplasia, or strictures causes hydronephrosis and loss of renal parenchyma if not relieved promptly |
IRIS Staging of CKD in Dogs
The International Renal Interest Society (IRIS) staging system is the universally used classification for CKD severity in dogs and cats. It is based on fasting serum creatinine from at least two measurements on separate days when the dog is stable and well-hydrated, supplemented by SDMA, urine protein:creatinine ratio (UPC), and blood pressure. IRIS staging guides treatment recommendations and prognosis.
| IRIS Stage | Creatinine (mg/dL) | SDMA (mcg/dL) | Clinical Status | Estimated Function Remaining |
|---|---|---|---|---|
| Stage 1 | Below 1.4 | 14 to 18 (borderline-elevated) | No azotemia; CKD suspected by other markers (persistent proteinuria, abnormal imaging, low urine specific gravity) | Greater than 33% |
| Stage 2 | 1.4 to 2.8 | 18 to 35 | Mild azotemia; often no clinical signs or only mild PU/PD | Approximately 25 to 33% |
| Stage 3 | 2.9 to 5.0 | 35 to 54 | Moderate azotemia; clinical signs typical: PU/PD, weight loss, decreased appetite, lethargy, vomiting; uremic halitosis may develop | Approximately 10 to 25% |
| Stage 4 | Above 5.0 | Above 54 | Severe azotemia/uremic crisis; profound lethargy, vomiting, oral ulcers (uremic stomatitis), seizures, coma possible; end-stage | Less than 10% |
IRIS further sub-stages dogs by proteinuria (non-proteinuric: UPC below 0.2; borderline: UPC 0.2 to 0.5; proteinuric: UPC above 0.5) and blood pressure (Stage 1: below 140 mmHg; Stage 2: 140 to 159; Stage 3: 160 to 179; Stage 4: 180 or above). Both proteinuria and hypertension independently worsen prognosis and drive progression, and both are managed as part of the overall CKD treatment plan regardless of creatinine stage.
Symptoms of Kidney Disease in Dogs
Early Signs (IRIS Stage 1 to 2)
Early-stage CKD is often completely asymptomatic and detected only on routine bloodwork or urinalysis. When signs are present, they tend to be subtle:
- Polyuria and polydipsia (PU/PD): The failing kidney loses concentrating ability (isosthenuria: urine specific gravity 1.008 to 1.012; hyposthenuria: below 1.008); more water must be drunk to excrete waste products in dilute urine; this is often the earliest sign owners notice
- Mild weight loss, particularly loss of muscle mass over the topline and hindquarters
- Slightly reduced appetite or increased pickiness about food
- Slightly less energy or reduced enthusiasm for exercise
Later Signs (IRIS Stage 3 to 4)
- Nausea and vomiting: Uremic toxins (particularly guanidine compounds and middle-molecule uremic toxins) act on the chemoreceptor trigger zone to cause nausea; dogs often vomit bile or foam in the morning; anorexia worsens
- Uremic halitosis: A characteristic ammonia-like or urine-like odor to the breath from expired urea and uremic volatile organic compounds
- Oral ulcers (uremic stomatitis): Ammonia produced from urea by oral bacteria causes mucosal ulceration; tongue tip necrosis can occur in severe uremia
- Anemia of chronic kidney disease: Failing kidneys produce insufficient erythropoietin; normocytic normochromic non-regenerative anemia develops; pale gums, weakness, rapid breathing from reduced oxygen-carrying capacity
- Hypertension-related signs: Sudden blindness from hypertensive retinal detachment (the retinas appear detached on fundic exam; the pupils are dilated and non-responsive); behavioral changes from hypertensive encephalopathy; nosebleeds
- Uremic encephalopathy: Disorientation, seizures, stupor in late Stage 4; indicates critically elevated uremic toxins affecting the blood-brain barrier
Diagnosing and Monitoring CKD
| Test | What It Evaluates | Frequency |
|---|---|---|
| Serum creatinine and BUN | Azotemia severity; IRIS staging; creatinine is muscle-mass dependent (thin dogs may have low creatinine despite significant CKD) | Every 3 to 6 months (stable Stage 2); every 1 to 3 months (Stage 3 to 4) |
| SDMA (symmetric dimethylarginine) | Earlier CKD detection; correlates with GFR; less affected by muscle mass than creatinine; ideal for senior screening | Annually (senior wellness); with every recheck in known CKD |
| Urinalysis with urine specific gravity (USG) | Concentrating ability; isosthenuria (USG 1.008 to 1.012) in dogs with clinical signs indicates significant renal dysfunction; glucosuria, hematuria, casts (especially granular and cellular casts indicating tubular damage) | Every recheck |
| Urine protein:creatinine ratio (UPC) | Quantifies proteinuria; above 0.5 is pathologic in dogs; proteinuria independently accelerates CKD progression and requires treatment | Every 1 to 3 months |
| Blood pressure (Doppler or oscillometric) | Hypertension is common and causes additional kidney damage plus target organ injury; goal is systolic below 140 mmHg | Every recheck |
| Serum phosphorus | Phosphorus retention drives renal secondary hyperparathyroidism and CKD progression; target serum phosphorus Stage 2: below 4.5 mg/dL; Stage 3: below 5.0; Stage 4: below 6.0 | Every recheck |
| Complete blood count | Screens for anemia of CKD (non-regenerative anemia), infection, concurrent disease | Every 3 to 6 months |
| Abdominal ultrasound | Kidney size, architecture, cortical echogenicity (increased echogenicity indicates fibrosis), presence of cysts (polycystic kidney disease), pyelonephritis changes, obstructive uropathy | At diagnosis; annually or when rapid progression detected |
| PTH (parathyroid hormone) | Elevated in renal secondary hyperparathyroidism; useful if phosphorus control is unclear or calcitriol therapy is being considered | As needed; specialist guidance |
Treatment of CKD in Dogs
Renal Diet: Phosphorus and Protein Restriction
The prescription renal diet is the most evidence-backed long-term intervention for CKD in dogs. Renal diets are formulated to be: restricted in phosphorus (the primary benefit), moderate in high-biological-value protein (enough to maintain lean body mass without generating excess nitrogenous waste), supplemented with omega-3 fatty acids (anti-inflammatory effects on glomeruli), and palatable enough for dogs with uremic nausea and appetite suppression. Key products: Hills k/d, Royal Canin Renal Support, Purina NF Kidney Function. Renal diet introduction should be gradual (2 to 4 weeks of transition) to avoid food aversion. If a dog refuses the renal diet, a homemade diet formulated by a board-certified veterinary nutritionist (dacvn.org) is a legitimate alternative for maintaining phosphorus restriction with adequate protein. The goal is phosphorus restriction; how it is achieved matters less than whether it is consistently achieved.
Phosphate Binders
When diet alone is insufficient to reach serum phosphorus targets, phosphate binders administered with meals bind dietary phosphorus in the gastrointestinal tract before absorption. Options:
- Aluminum hydroxide: Highly effective; can be added to food; long-term use carries risk of aluminum accumulation and toxicity; used at lowest effective dose for shortest necessary duration
- Calcium carbonate: Available over-the-counter (Tums); widely used; avoid calcium acetate in hypercalcemic dogs (some CKD dogs develop hypercalcemia)
- Lanthanum carbonate (Fosrenol): Very effective; no aluminum or calcium accumulation concern; expensive
- Chitosan-based binders (Epakitin): Chitosan plus calcium carbonate; marketed specifically for cats and dogs with CKD; milder phosphorus binding; useful in early-to-mid stages
Blood Pressure Management
The goal of antihypertensive therapy in CKD is systolic blood pressure below 140 mmHg to reduce further renal damage and prevent target organ injury. First-line agent: amlodipine (a calcium channel blocker), at 0.1 to 0.2 mg/kg orally once daily. ACE inhibitors (enalapril, benazepril) and angiotensin receptor blockers (telmisartan) reduce intraglomerular hypertension and proteinuria through their effects on the renin-angiotensin system and are added when proteinuria is present (UPC above 0.5) or when systolic blood pressure remains elevated after amlodipine. Telmisartan (Semintra) is approved for the reduction of proteinuria in cats and is used off-label in dogs; it has become a preferred ARB in small animal nephrology due to its once-daily dosing and tolerability.
Anti-Proteinuria Therapy
Proteinuria (UPC above 0.5) in CKD is both a marker of severity and an independent driver of progression: filtered protein in the tubules is directly nephrotoxic and amplifies interstitial fibrosis. ACE inhibitors (benazepril 0.5 mg/kg once daily, enalapril 0.5 mg/kg twice daily) or ARBs (telmisartan 1 mg/kg once daily) reduce glomerular filtration pressure and protein leakage. Omega-3 fatty acid supplementation (EPA and DHA from fish oil) at approximately 40 mg EPA+DHA per kilogram per day has anti-inflammatory effects at the glomerular level and mild antiproteinuric effects.
Managing Uremic Signs: Nausea, Appetite, Anemia
- Anti-emetics: Maropitant (Cerenia 1 mg/kg orally or SQ daily) is the most effective anti-nausea drug for uremic nausea; ondansetron (0.1 to 0.2 mg/kg orally twice daily) is a useful adjunct; controlling nausea improves appetite and quality of life substantially
- Appetite stimulants: Mirtazapine (Mirataz transdermal; 1.88 mg per cat but dosing in dogs is per weight; typically 0.6 mg/kg orally every 72 hours, maximum 30 mg) is the most effective appetite stimulant in dogs with CKD; capromorelin (Entyce, an oral ghrelin receptor agonist, 3 mg/kg orally once daily) is FDA-approved for appetite stimulation in dogs and is very well tolerated
- Anemia of CKD: Darbepoetin alfa (Aranesp), a long-acting synthetic erythropoietin, is used when PCV falls below approximately 20 to 25% and anemia is symptomatic; dosing is 0.5 to 1.0 mcg/kg SQ weekly initially; risk of pure red cell aplasia from anti-erythropoietin antibody formation is a known complication of both darbepoetin and recombinant human erythropoietin (Epogen); iron supplementation (ferrous sulfate or dextran iron) should accompany erythropoietic therapy
- Subcutaneous fluids: Many Stage 3 to 4 dogs benefit from periodic or daily subcutaneous fluid administration at home to maintain hydration and support urinary excretion of waste products; lactated Ringer’s solution or 0.9% saline, 75 to 150 mL per administration depending on dog size, delivered via a needle under the scruff; owners can be taught this technique at home and it substantially extends quality and quantity of life in many late-stage CKD dogs
- Calcitriol: Active vitamin D at low doses (2 to 3 ng/kg orally every other day, given on an empty stomach, separate from phosphorus binders) suppresses PTH in dogs with documented renal secondary hyperparathyroidism; may slow CKD progression through direct effects on renal cells; requires monitoring of ionized calcium and phosphorus; use only after phosphorus is controlled
Age-Specific Considerations
Young Dogs (Under 5 Years)
- CKD in young dogs is uncommon and should prompt investigation for hereditary or congenital causes: renal dysplasia (abnormal kidney development), polycystic kidney disease, or breed-specific hereditary nephropathy
- Bull Terriers and Miniature Bull Terriers: screen with urinalysis and UPC from age 1 year; hereditary nephritis in this breed typically presents between 1 and 8 years; genetic test (Embark, breed-specific panels) available
- Soft Coated Wheaten Terriers: screen for protein-losing nephropathy with UPC annually from age 2 to 3 years; concurrent protein-losing enteropathy in some affected dogs; this breed’s PLE/PLN combination carries a guarded prognosis
- Leptospirosis is a significant cause of acute kidney injury that can progress to CKD in young dogs with outdoor or wildlife exposure; 4-serovar leptospirosis vaccine (Zoetis Vanguard L4 or Nobivac Lepto4) is strongly recommended in endemic areas
Middle-Aged Dogs (5 to 10 Years)
- Annual senior wellness panels including creatinine, BUN, SDMA, and urinalysis should begin no later than age 7 in large and giant breeds, and age 8 to 9 in small and medium breeds; SDMA elevation before creatinine rises is the earliest detectable signal of CKD and allows intervention before significant nephron loss
- Concurrent hyperadrenocorticism (Cushing’s disease) at this age group causes hypertension and increased susceptibility to urinary tract infections, both of which accelerate CKD; any middle-aged dog with CKD and classic Cushing’s signs should be evaluated with LDDST
- Lyme-endemic areas: Lyme nephritis (Borrelia-associated immune complex glomerulopathy) most commonly presents between ages 5 and 10 in at-risk breeds (Labrador Retrievers, Golden Retrievers, Bernese Mountain Dogs); annual 4Dx Plus testing with UPC evaluation in seropositive dogs is the current standard of care
- NSAIDs prescribed long-term for arthritis in middle-aged dogs are a significant nephrotoxicity risk; dehydration during illness, anesthesia, or hot weather dramatically increases NSAID nephrotoxicity; baseline and periodic renal panels are essential in dogs on chronic NSAID therapy
Senior Dogs (10+ Years)
- CKD is the second most common cause of non-accidental death in dogs over 10 years; approximately 10 percent of dogs over 15 years have some degree of CKD; prevalence increases substantially with each year of age beyond 10
- Concurrent hypertension in senior CKD dogs should be assessed with every visit; sudden blindness from hypertensive retinal detachment is an emergency; blood pressure measurement at every senior wellness visit, even in dogs without known CKD, is now standard of care at most referral practices
- Muscle wasting (sarcopenia) in senior dogs makes creatinine a particularly unreliable marker of CKD severity; a very lean senior dog may have a creatinine of only 1.8 mg/dL despite being functionally Stage 3 or higher; SDMA combined with USG and UPC gives a much more accurate picture than creatinine alone
- Quality of life decisions in Stage 4 CKD: when uremic signs can no longer be controlled with anti-emetics, subcutaneous fluids, and appetite stimulants, and the dog is no longer eating, drinking, or engaging with the family, a quality-of-life conversation with the veterinarian about humane euthanasia is appropriate and kind
US Cost Overview for CKD Management
| Item | Typical US Cost |
|---|---|
| Initial CKD workup (chemistry, SDMA, UA, UPC, CBC, blood pressure, ultrasound) | $350 to $800 |
| Quarterly recheck (chemistry, UA, UPC, blood pressure) | $120 to $280 |
| Prescription renal diet (Hills k/d, 27.5-lb bag) | $85 to $110 |
| Amlodipine (monthly, generic) | $15 to $35 |
| Benazepril or enalapril (monthly, generic) | $15 to $40 |
| Telmisartan (Semintra, monthly) | $50 to $100 |
| Maropitant/Cerenia (30-tablet pack) | $50 to $100 |
| Capromorelin/Entyce (monthly) | $60 to $130 |
| Subcutaneous fluid supplies (1-liter bag LRS + needles) | $15 to $35 per bag |
| Darbepoetin alfa (Aranesp, per injection) | $60 to $150 |
| Hospitalization for uremic crisis (3 to 5 days) | $1,200 to $4,000 |
| Annual CKD management (stable Stage 2 to 3) | $1,500 to $4,000 |
Myths and Facts About Dog Kidney Disease
My dog’s bloodwork was normal last year, so it definitely does not have kidney disease now.
CKD is progressive, and the rate of progression is variable and unpredictable. A dog with completely normal creatinine and BUN last year can have Stage 2 or even Stage 3 CKD this year if nephron loss has accelerated due to a new concurrent illness, acute kidney injury from an NSAID or toxic exposure, or simply the natural progression of underlying renal disease. The kidneys’ functional reserve means that creatinine can remain normal until 75 percent of nephron mass is lost; a jump from “normal” to Stage 3 on a single year’s recheck is not rare. Annual SDMA screening in senior dogs catches the earlier stages of this progression before creatinine rises. Any dog 9 years or older should have annual bloodwork with SDMA regardless of apparent health.
High-protein diets cause kidney disease in dogs.
This is one of the most persistent myths in small animal nutrition and it has been studied directly in dogs. Feeding a high-protein diet to a dog with normal kidney function does not cause or accelerate the development of CKD. In dogs with already-diagnosed CKD, protein restriction reduces the generation of nitrogenous waste products and may reduce uremic signs, but excessive protein restriction causes muscle wasting and malnutrition; current IRIS guidelines recommend moderate protein restriction (not severe restriction) in CKD, maintaining enough high-biological-value protein to support lean body mass. Phosphorus restriction in the renal diet is the intervention with strong evidence of slowing progression, not protein restriction per se. Feeding a high-quality, complete-and-balanced adult maintenance diet to a healthy dog does not damage its kidneys.
Once a dog is diagnosed with kidney disease, there is nothing to do but wait.
Early-to-moderate CKD (IRIS Stage 2 and 3) can be substantially managed to slow progression and maintain quality of life for months to years. The tools are specific and evidence-based: phosphorus restriction via renal diet and phosphate binders, blood pressure control with amlodipine and/or ACE inhibitor or ARB, proteinuria management, home subcutaneous fluids for hydration support, and anti-nausea therapy to maintain appetite. Dogs in IRIS Stage 2 with appropriate management can remain stable and feel well for 1 to 3 years or more. End-stage (Stage 4) CKD with severe uremic crisis carries a much shorter prognosis, but even then, medical management of symptoms can often provide additional weeks to months of reasonable quality of life before the decision for euthanasia becomes appropriate.
Red Flags: Signs That Mean See a Vet Right Away
- Sudden complete loss of vision (dilated pupils that do not respond to light, running into furniture) in a dog with known CKD or hypertension; hypertensive retinal detachment is a same-day emergency; blood pressure must be lowered urgently to prevent permanent blindness
- Vomiting repeatedly, refusing all food and water, or profound lethargy in a known CKD dog; may indicate uremic crisis, acute-on-chronic kidney injury, or another destabilizing event requiring hospitalization and IV fluids
- Collapse, seizures, or disorientation in a dog with known kidney disease; uremic encephalopathy or hypertensive encephalopathy are emergencies
- Oral ulcers (raw, red sores on the tongue tip or gum margins) combined with ammonia-odor breath; indicates severe uremia requiring immediate assessment of creatinine and electrolytes
- Pale or white gums with rapid breathing and extreme weakness in a dog with CKD; signs of severe anemia of chronic kidney disease requiring urgent CBC and potentially transfusion or erythropoietin therapy
- Any known CKD dog that stops drinking water; dehydration rapidly worsens azotemia in dogs with impaired renal concentrating ability
- Rapid weight loss (more than 10 percent body weight over 2 to 4 weeks) in a dog being managed for CKD; indicates loss of disease control, possible acute exacerbation, or concurrent illness
Frequently Asked Questions About Dog Kidney Disease
What is the difference between acute kidney injury (AKI) and chronic kidney disease (CKD)?
Acute kidney injury (AKI) is a sudden, rapid decline in kidney function occurring over hours to days, caused by a specific insult: toxin (antifreeze, grapes, NSAIDs, aminoglycoside antibiotics), severe dehydration, infection (leptospirosis), urinary obstruction, or reduced kidney blood flow (anesthesia complications, shock). AKI is potentially reversible if the inciting cause is removed and the dog receives intensive supportive care (IV fluids, sometimes dialysis). Chronic kidney disease is a gradual, irreversible loss of nephrons over months to years, with progressive scarring that cannot be reversed. AKI and CKD can overlap: a dog with underlying CKD is more susceptible to AKI from any additional insult (“acute-on-chronic”), and AKI from a severe event can cause permanent nephron loss that leaves a dog with residual CKD even after recovery.
Can a dog with kidney disease eat regular dog food?
A dog with IRIS Stage 1 CKD or borderline SDMA elevations can often continue on a high-quality regular maintenance diet while the situation is monitored closely. From IRIS Stage 2 onward, a prescription renal diet is strongly recommended because the phosphorus restriction has clear evidence of slowing disease progression. If the dog refuses all prescription renal foods, a homemade renal diet formulated by a board-certified veterinary nutritionist (DACVN) is a valid alternative that maintains the phosphorus restriction goal. The worst outcome is a dog that eats nothing due to forced renal diet transition while still consuming a high-phosphorus diet in treats and table scraps; gradual transition with veterinary support and palatability enhancers (warm water added to kibble, low-sodium chicken broth) improves acceptance.
How long can a dog live with kidney disease?
Survival depends heavily on the IRIS stage at diagnosis and how well the disease is managed. IRIS Stage 2 dogs on appropriate management (renal diet, blood pressure control, phosphorus management) can be stable for 1 to 4 years or more. IRIS Stage 3 dogs have median survival times in published studies of approximately 200 to 400 days, with wide individual variation; well-managed Stage 3 dogs frequently live 1 to 2 years. IRIS Stage 4 dogs have median survival of weeks to a few months, though home subcutaneous fluid therapy and anti-nausea management can maintain acceptable quality of life for months in some dogs. These are population medians; individual dogs vary considerably. A dog diagnosed early and managed consistently from Stage 2 onward will almost always outlive a dog diagnosed for the first time in uremic crisis at Stage 4.
What is SDMA and why is it important for early CKD detection?
Symmetric dimethylarginine (SDMA) is a methylated amino acid produced at a constant rate from normal protein metabolism throughout the body and eliminated almost exclusively by the kidneys. Unlike creatinine, which is affected by muscle mass (thin or cachectic dogs have artificially low creatinine despite significant CKD), SDMA is muscle-mass independent and correlates closely with glomerular filtration rate. Critically, SDMA rises above the normal range when approximately 40 percent of kidney function is lost, compared to creatinine which requires 75 percent loss to become elevated. This earlier detection window of approximately 17 months ahead of creatinine in studies allows veterinarians and owners to begin interventions (renal diet, phosphorus management, blood pressure monitoring) before the disease has progressed to the point where creatinine is elevated. IDEXX SDMA is now included in their routine Catalyst chemistry analyzer panels, making it a standard part of senior wellness screening at most veterinary practices.
Should I give my CKD dog subcutaneous fluids at home?
Home subcutaneous fluid therapy is one of the most impactful management tools for IRIS Stage 3 to 4 CKD dogs and is strongly recommended when the dog is showing signs of dehydration, nausea, or declining food intake that cannot be fully managed by other means. The technique is teachable to most owners and most dogs tolerate it well after a brief learning period. The benefit is significant: diluting uremic toxins, maintaining adequate perfusion of the remaining nephrons, and supporting the dog’s ability to excrete waste in dilute urine. The typical protocol is 75 to 150 mL of lactated Ringer’s solution (LRS) given subcutaneously over the scruff on alternate days or daily, depending on the dog’s hydration status and stage. Your veterinarian will demonstrate the technique (it requires a needle inserted under the scruff, a fluid bag, and an administration set) and provide a prescription for the fluids. Many owners report that home fluid therapy significantly improves their dog’s quality of life and extends survival.
My dog has kidney disease and arthritis. Can I still give it NSAIDs for pain?
This is one of the most difficult management dilemmas in senior dog medicine. NSAIDs (meloxicam, carprofen, deracoxib, grapiprant) are highly effective for osteoarthritis pain but carry real nephrotoxicity risk in dogs with pre-existing CKD, particularly in IRIS Stage 3 and 4. The risk is dramatically increased by dehydration, concurrent diuretics, anesthesia, or any acute illness. The general approach in CKD dogs: IRIS Stage 1 to 2 with mild azotemia and well-controlled blood pressure, short-term NSAID use with close renal monitoring may be acceptable with adequate hydration; IRIS Stage 3 to 4, avoid NSAIDs and use alternative analgesia instead. Alternative pain management options for CKD dogs with osteoarthritis include: gabapentin (no renal toxicity; dose reduction needed in severe CKD), tramadol (limited efficacy for OA alone but useful as adjunct), Librela (bedinvetmab, anti-NGF monoclonal antibody, monthly SQ injection, no renal toxicity, highly effective for OA pain), and rehabilitation therapy/acupuncture/underwater treadmill for physical pain management. Librela has become a significant advance for managing OA pain in CKD dogs that cannot safely receive NSAIDs.
What breeds are at highest risk of hereditary kidney disease?
Several breeds carry known genetic mutations affecting kidney structure or function: Bull Terriers and Miniature Bull Terriers (X-linked hereditary nephritis from a collagen IV alpha-3/4 chain mutation, similar to human Alport syndrome; typically presents between 1 and 8 years with progressive proteinuria and CKD); Soft Coated Wheaten Terriers (protein-losing nephropathy combined with protein-losing enteropathy; hypoalbuminemia, edema, ascites; poor prognosis in severely affected dogs); Cairn Terriers (polycystic kidney disease, similar to the cat PKD mutation but mapped to a different locus; cysts visible on ultrasound); Doberman Pinschers (membranoproliferative glomerulopathy); Cocker Spaniels (familial nephropathy, early onset); Bernese Mountain Dogs (immune-complex glomerulonephritis often secondary to Borrelia). Genetic testing panels for breed-specific mutations are available through Embark, UC Davis Veterinary Genetics Laboratory, and breed-specific health registries.
For more guides on keeping your dog healthy, browse all our Dog Health articles.
Explore Dog Health Articles